What do peptide packaging label documentation requirements include for identity?
Peptide packaging label documentation requirements separate a primary label, legible at vial scale, from an extended batch record that holds chromatograms, spectra and calculations. The primary label should carry a stable material code, the lot or batch number, a container identifier, the sequence name written from the amino terminus to the carboxyl terminus, the residue count, and a document identifier for the current certificate of analysis. Sequence should exist as a controlled one-letter string and, on the secondary label or in the batch record, in three-letter code so that ambiguous characters are not the only copy. Calculated monoisotopic mass and average mass should both appear, with the mass definition: free peptide, prevailing ion, or stated salt. Omitting that definition makes a later mass comparison look like an analytical failure when only the arithmetic object has changed.
Counterion sits in the same identity block. Acetate, trifluoroacetate and chloride are composition facts, not interchangeable names for one solid. Gross mass of a lyophilised vial is not net peptide amount. If net peptide content is reported, the linked record should state the basis, such as amino-acid analysis or another orthogonal content measurement, and whether water and counterion were accounted for. A purity figure on the primary label, if printed at all, should name the method class, the detection wavelength or detector, and the document that holds the peak table. Area-percent purity is not an assay and is not a content result. The identity block should name the chemical form in the container: the intended main component, not a mixture of related substances, and not a precursor unless the precursor is the specified analyte. Defensin processing shows precursor polypeptides converted to shorter mature peptides, so a shared family name can hide two molecular entities (PMID:1339298).
How should termini and processing state be written on the label?
Terminal chemistry changes the elemental formula and the fragment-ion series used to assign sequence. Isobaric peptide termini labelling places isobaric information at both the amino terminus and the carboxyl terminus so that quantification can use fragment ions from either end (PMID:22665299). A record that prints only a name and a mass, without stating whether the amino terminus is free, acetylated or cyclised to pyroglutamate, and whether the carboxyl terminus is the free acid or an amide, leaves that assignment under-specified. Those states should be controlled terms on the secondary label and in the identity header, and the calculated mass should be regenerated from the same terms. If the observed intact mass matches the amide rather than the acid, the record should say so.
Processing state is not the same field as a terminal modification. Surfactant protein-C proprotein carries targeting motifs in the amino-terminal flanking domain that are cleaved in late compartments, so the proprotein and the cleaved species are not documentation synonyms (PMID:11245624). Defensin maturation likewise converts longer precursors in immature myeloid cells into a shorter mature peptide (PMID:1339298). The label should state "precursor", "processing intermediate" or "mature sequence" when more than one form is chemically plausible, and it should give the residue range. A flanking sequence removed before the lot was closed is process history, not part of the specified identity, unless residual precursor is the specified analyte.
Where the sequence contains cysteine, disulfide connectivity should be recorded as "expected" or "not determined". An intact mass can fit more than one pairing, so a mass match must not be printed as proof of connectivity. Truncations, deletions and incomplete deprotection products stay in the related-substances table, with relative retention or observed mass. They must not be promoted into the primary identity name. The primary name is the specified component. The impurity table is what else was observed above the reporting threshold of the stated method.
Which modification and isotopic-standard fields must the record carry?
A modification can be the feature that defines the analyte. Work on the Golgi sorting receptor muclin showed binding to pancreatic zymogens through sulfated O-linked oligosaccharides, so a sulfated glycan is a specified structure, not a decorative aside to an unmodified sequence (PMID:15292166). The batch record should carry a modification inventory with site, type and status, where status is "specified", "observed", "not detected by the stated method" or "not tested". Entries commonly required for synthetic research peptides include amino-terminal acetylation, carboxyl-terminal amidation, methionine oxidation, asparagine or glutamine deamidation, pyroglutamate, disulfide formation and residual protecting groups. Each entry should say whether it belongs to the intended structure or to an impurity class. If sulfation or glycosylation is the specified form, it belongs in the primary identity string.
Isotopic composition must be equally explicit. The PSAQ(+1) approach to absolute quantification uses a carbon-13, single-label protein standard, coisolation of peptide pairs, and LC-PRM (PMID:42400479). The labelled standard and the unlabelled analyte are a pair, not one material under two names. A container of standard should state the isotope, the nominal number of labelled atoms, the labelling scheme if known, and a controlled term such as "quantification standard". The analyte container should state "unlabelled" or "natural abundance" when a labelled standard is in the same study, so sample names cannot be transposed. The batch record should name the peptide pair used for coisolation and the method identifier for the acquisition.
For ordinary lots, the printed monoisotopic mass should match the elemental formula of the stated form, including specified modifications and excluding counterion unless the record says otherwise. A metal adduct or a particular charge state belongs in the spectral note, not as a silent edit to molecular weight. If a modification site is reassigned, label revision and certificate revision should move together, and the superseded document identifier should remain traceable.
How are mass-spectrometric identity markers tied to the container label?
Mass-spectrometric identity is only as specific as the markers named in the record. Detection of CP4 EPSPS in genetically modified soya and maize rested on characteristic peptides of that protein, not on a generic statement that a mass spectrometer had been used (PMID:17200978). "Confirmed by MS", with no mass, charge state or method identifier, cannot be checked against the container. The identity header should quote calculated monoisotopic mass, observed mass or m/z, charge state if an ion is reported, and the mass-accuracy window. It should state whether the evidence is an intact-mass measurement, a peptide-map marker set, or a parallel-reaction-monitoring acquisition. Those are different claims. An intact mass supports elemental composition within the stated tolerance. It does not, by itself, prove the residue sequence.
Where sequence evidence is the specified test, the record should name the marker ions or peptide segments. In a labelled-standard workflow, coisolation of peptide pairs means the analyte transition and the standard transition are acquired as a designed pair (PMID:42400479). The certificate should list that pair, the precursor isolation context, and the result against the stated acceptance criterion. The vial label needs the method identifier and the document identifier, provided both resolve to that list. A mass quoted from a different method revision than the archived spectrum is a traceability failure even if both numbers look plausible.
Concordance is the practical test. The sample name in the chromatographic sequence table, the vial identifier, the lot number on the primary label, and the certificate identity header should be the same string or an explicitly mapped set. Relative retention times for related substances should point to the same lot. An unknown peak code must not be absorbed into the main-component name. Unknown remains unknown until a reviewer accepts a structural assignment. System-suitability injections, blanks and bracketing standards stay in the sequence record that the document identifier retrieves.
How should traceability fields and acceptance language be read together?
A label that cannot be joined to raw data is an uncheckable claim. The minimum join is lot number, container identifier, method identifier, analysis date, certificate document identifier and revision. The batch record adds the chromatography sample-set identifier, the spectral file identifier, the reference-standard lot, and the analyst and reviewer identifiers. Records should be attributable, legible, contemporaneous, original and accurate: the transcriber is identifiable, the label matches the reviewed certificate, and a correction is a new revision. Lot genealogy should distinguish synthesis or isolation lot, purification lot, and packaging lot. A shared certificate should state the container range and whether the result is per container or for the lot.
Mismatch patterns should be defined in the template. A one-dalton offset often indicates acid versus amide, or a monoisotopic mass printed as an average mass. A larger offset may indicate a missing modification, a counterion included in only one calculation, or a precursor sequence printed against a mature mass. A purity result without wavelength, reporting threshold and peak table cannot be compared across lots. A net-content result without counterion and a water-content basis cannot be compared with gross mass. Superseded label revisions remain archived with a reason for change.
Acceptance language compares a reported result with a pre-stated limit. A conforming identity result means the stated test met the stated criterion, such as observed mass inside the stated window or specified marker peptides detected. It does not mean every theoretical impurity was excluded. A conforming purity result means the figure from the stated method met the stated limit, including any rule that excludes solvent peaks. Reporting, identification and qualification thresholds are different numbers and should not be collapsed into a claim that impurities are absent. The research-use statement records that the package is analytical documentation for laboratory material. It is not a claim about biological effect. Numerical closure remains the reviewer check: the printed monoisotopic mass must follow from the stated sequence, termini and modifications, and the peak table must reconcile with the purity statement.
Frequently asked questions
What is the difference between the vial label and the certificate of analysis?
The vial label is the short index fixed to the container: material code, lot, container identifier, sequence name and a document identifier. The certificate of analysis is the reviewed report that holds identity, purity and content results against stated limits, with method identifiers and, where applicable, peak tables and masses. Neither replaces the raw chromatogram or spectrum. A result on the label is interpretable only when the document identifier retrieves the certificate revision that was current for that lot.
Why must terminal chemistry be written explicitly?
Amino-terminal and carboxyl-terminal states change elemental formula and the fragment ions used to assign sequence. Isobaric peptide termini labelling treats both ends as analytical sites, which is useful only if the record states whether each end is free, acetylated, amidated or otherwise modified (PMID:22665299). Acid versus amide is a common one-dalton ambiguity. If the printed mass was calculated for a different terminus from the material in the container, the mismatch is documentary, not necessarily an instrumental failure. The controlled term and the mass definition should be the same object.
How should an isotopically labelled standard be distinguished in the documentation?
A labelled quantification standard is not the analyte. Under a PSAQ(+1)-style design, a carbon-13 single-label protein standard is coisolated as a peptide pair with the unlabelled analyte and measured by LC-PRM (PMID:42400479). The standard container should name the isotope, the nominal label count and a term such as "quantification standard". The analyte record should state natural abundance where both are in the same study. The method identifier should point to the peptide pair. Transposing the two names would make the amount uninterpretable.
Does a purity percentage on a label replace the chromatogram?
No. A percentage is a reported result under a stated method, wavelength or detector, integration rule and reporting threshold. Without those parameters, and without the peak table, the number cannot be reconstructed or compared with another lot. Area-percent purity is not an assay and is not net peptide content. Unknown peaks remain unknown until a reviewed assignment. The label may cite the figure only as a pointer to the certificate revision that holds the chromatogram and the acceptance limit.
Which mass value should the documentation quote?
Quote both calculated monoisotopic mass and average mass when the secondary label or the identity header has room, and state which species the calculation describes: free peptide, specified salt, or a measured ion. The observed mass or m/z, charge state and mass-accuracy window belong beside the calculated value. Characteristic peptide markers, as used in mass-spectrometric detection of a named protein in a complex matrix, should be named when sequence-level evidence is the specified test (PMID:17200978). A bare "MS confirmed" line is not a mass value.
Are these notes a statutory packaging standard?
No. The cited papers are analytical characterisation studies, not packaging statutes. They are used here because they show why termini, processing state, modifications, isotopic standards and named peptide markers change molecular identity (PMID:22665299; PMID:1339298; PMID:42400479). Laboratories can adopt the field list as a research-record convention so that a container, a certificate and a raw-data file describe the same chemical object. The notes do not set legal labelling duties, and they do not address use outside laboratory research.
References
- PMID:22665299 — A rapid approach for isobaric peptide termini labeling — Methods Mol Biol — 2012
- PMID:1339298 — Posttranslational processing of defensins in immature human myeloid cells — Blood — 1992
- PMID:42400479 — PSAQ(+1): Absolute Protein Quantification Using a (13)C(1)-Labeled Protein Standard, Coisolation of Peptide Pairs and LC-PRM — Anal Chem — 2026
- PMID:11245624 — Post-translational processing of surfactant protein-C proprotein: targeting motifs in the NH(2)-terminal flanking domain are cleaved in late compartments — Am J Respir Cell Mol Biol — 2001
- PMID:17200978 — Mass spectrometric detection of CP4 EPSPS in genetically modified soya and maize — Rapid Commun Mass Spectrom — 2007
- PMID:15292166 — Binding of the Golgi sorting receptor muclin to pancreatic zymogens through sulfated O-linked oligosaccharides — J Biol Chem — 2004
Research use only
This article is provided for laboratory research and educational purposes only. Products referenced are not for human or veterinary use. ClaraScience makes no therapeutic, medical, or efficacy claims, and nothing here constitutes medical advice.
